Preventive health measures in inflammatory bowel disease

Table 5 Vaccination in special populations of inflammatory bowel disease patients

Pregnancy
Category B	Category C	Category X
Influenza (LAIV)	PPSV 23	Varicella, if non-immune
		1 dose upon completion or termination of pregnancy and before discharge from health care facility.
		2nd dose 4-8 wk later.
Influenza (IIV)	Zoster
Boostrix (Tdap)	Adacel (Tdap)
1 dose of Tdap vaccine during each pregnancy regardless of immunization status	1 dose of Tdap vaccine during each pregnancy regardless of immunization status
HPV 4, HPV 2	Meningococcus
PCV 13	Hepatitis A and B vaccine
	MMR, if non-immune
	1 dose upon completion or termination of pregnancy and before discharge from health care facility.
	2nd dose 4-8 wk later.
The IBD traveler
Vaccine	Type	Travel related indication
Yellow fever	Live	Parts of South America and sub-Saharan Africa
Typhoid	Live and Inactivated	Asia, Africa, Central and South America, The Caribbean, Oceania
Polio	Live
Influenza	Inactivated
BCG vaccine	Live	Travel to highly endemic area > 1 yr
Hepatitis A	Inactivated	Central or South America, Mexico, Asia( except Japan), Africa, Eastern Europe
Meningococcal vaccine	Inactivated	sub-Saharan Africa, Saudi Arabia (during Hajj and Umrah pilgrimage)
Japanese encephalitis virus	Inactivated	Rural Japan

Adapted from Chaudrey et al[55].